Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142493 · ClinicalTrials.gov registry record · Phase 1
Effect of Affective Content on Drug Induced Amnesia of Episodic Memory
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 79
- Enrollment target
NCT00142493: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00142493 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00142493, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this research is to understand how some of the drugs commonly used in anesthesia impair memory. We are particularly interested in whether the emotion associated with a memory influences how well these drugs are able to block memory. We are studying four commonly used drugs-propofol, thiopental, midazolam, and dexmedetomidine, all of which may have slightly differing effects. We will also study an inactive substance, called a placebo, that should have no effect. The results of this study will provide information that will be useful in understanding how memory works, how these drugs affect memory, and possibly why some people don't have their memory blocked as easily as others.
Interventions
- DRUG placebo
- DRUG Propofol
- DRUG Midazolam Hydrochloride
- DRUG Dexmedetomidine Hydrochloride
- DRUG Thiopental Sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00142493
The ClinicalTrials.gov registry entry for NCT00142493 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which placebo is the first listed.
NCT00142493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00142493 about?
NCT00142493 is a clinical study titled "Effect of Affective Content on Drug Induced Amnesia of Episodic Memory". The purpose of this research is to understand how some of the drugs commonly used in anesthesia impair memory. We are particularly interested in whether the emotion associated with a memory influences how well these drugs are able to block memory. We are studying four commonly used drugs-propofol, t...
What is the current status of trial NCT00142493?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 79 participants. The study started on 2004-09. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00142493?
The interventions under investigation include: placebo (DRUG), Propofol (DRUG), Midazolam Hydrochloride (DRUG), Dexmedetomidine Hydrochloride (DRUG), Thiopental Sodium (DRUG).
Who is sponsoring clinical trial NCT00142493?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.